Assertio Holdings, Inc. (ASRT) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ASRT Revenue Growth
Revenue Breakdown (FY 2025)
ASRT's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
ASRT Revenue Analysis (2014–2025)
As of May 8, 2026, Assertio Holdings, Inc. (ASRT) generated trailing twelve-month (TTM) revenue of $118.7 million, reflecting significant decline in growth of -57.9% year-over-year. The most recent quarter (Q4 2025) recorded $13.5 million in revenue, down 72.6% sequentially.
Looking at the longer-term picture, ASRT's 5-year compound annual growth rate (CAGR) stands at +1.9%, indicating moderate growth over time. The company achieved its highest annual revenue of $455.9 million in 2016.
Revenue diversification analysis shows ASRT's business is primarily driven by Product (75%), INDOCIN Products (12%), and Product, Other (7%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including PAHC (+32.4% YoY), AMRX (+8.0% YoY), and SUPN (+16.3% YoY), ASRT has underperformed the peer group in terms of revenue growth. Compare ASRT vs PAHC →
ASRT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $119M | -57.9% | +1.9% | -18.1% | ||
| $1.3B | +32.4% | +10.1% | 8.5% | ||
| $3.0B | +8.0% | +8.7% | -0.2% | ||
| $719M | +16.3% | +6.7% | -5.1% | ||
| $4.3B | -3.6% | +0.8% | 8.1% | ||
| $781M | +19.9% | +20.3% | 24.0% |
ASRT Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $118.7M | -5.0% | $83.3M | 70.2% | $-21,536,000 | -18.1% |
| 2024 | $125.0M | -17.8% | $85.7M | 68.6% | $-24,476,000 | -19.6% |
| 2023 | $152.1M | -2.7% | $125.0M | 82.2% | $-243,536,000 | -160.1% |
| 2022 | $156.2M | +40.7% | $137.5M | 88.0% | $39.4M | 25.2% |
| 2021 | $111.0M | +2.7% | $95.2M | 85.7% | $9.4M | 8.5% |
| 2020 | $108.1M | -52.9% | $92.3M | 85.4% | $-82,155,000 | -76.0% |
| 2019 | $229.5M | -26.4% | $220.0M | 95.9% | $-194,428,000 | -84.7% |
| 2018 | $311.8M | -18.1% | $293.3M | 94.1% | $43.7M | 14.0% |
| 2017 | $380.7M | -16.5% | $308.1M | 80.9% | $-42,180,000 | -11.1% |
| 2016 | $455.9M | +33.0% | $368.5M | 80.8% | $24.5M | 5.4% |
See ASRT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASRT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ASRT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonASRT — Frequently Asked Questions
Quick answers to the most common questions about buying ASRT stock.
Is ASRT's revenue growth accelerating or slowing?
ASRT revenue declined -57.9% year-over-year, contrasting with the 5-year CAGR of +1.9%. TTM revenue fell to $119M. This reverses the prior growth trend.
What is ASRT's long-term revenue growth rate?
Assertio Holdings, Inc.'s 5-year revenue CAGR of +1.9% reflects the variable expansion pattern. Current YoY growth of -57.9% is below this long-term average.
How is ASRT's revenue distributed by segment?
ASRT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.